Boron-containing small molecules

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Boron containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C549S213000

Reexamination Certificate

active

07816344

ABSTRACT:
This invention provides, among other things, novel oxaboroles which are monosubstituted at the 3-, 6-, or 7-position, or disubstituted at the 3-/6- or 3-/7- positions, which are useful for treating bacterial infections, pharmaceutical compositions containing such oxaboroles, as well as combinations of these oxaboroles with at least one additional therapeutically effective agent.

REFERENCES:
patent: 2260336 (1941-10-01), Prescott et al.
patent: 3873279 (1975-03-01), Singer
patent: 5688928 (1997-11-01), Stolowitz
patent: 5831045 (1998-11-01), Stolowitz et al.
patent: 5880188 (1999-03-01), Austin et al.
patent: 5962498 (1999-10-01), Driedger et al.
patent: 6083903 (2000-07-01), Adams et al.
patent: 6306628 (2001-10-01), Rothschild et al.
patent: 6369098 (2002-04-01), Pershadsingh et al.
patent: 6855848 (2005-02-01), Scherer et al.
patent: 7582621 (2009-09-01), Baker et al.
patent: 2003/0032673 (2003-02-01), Nagy
patent: 2004/0259842 (2004-12-01), Mikoshiba et al.
patent: 2005/0239170 (2005-10-01), Hedley et al.
patent: 2006/0009386 (2006-01-01), Stossel et al.
patent: 2006/0234981 (2006-10-01), Baker et al.
patent: 2007/0155699 (2007-07-01), Baker et al.
patent: 2007/0286822 (2007-12-01), Sanders et al.
patent: 2007/0293457 (2007-12-01), Baker et al.
patent: WO 2005013892 (2005-02-01), None
patent: WO 2006/089067 (2006-08-01), None
patent: WO 2007146965 (2007-12-01), None
Morissette et al. “High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.” Advanced Drug Delivery Reviews 2004, 56, 275-300.
Tschampel et al., J. Org. Chem. 1964, 29(8), 2168-72.
Vippagunta, Sudha R. “Crystalline Solids.” Advanced Drug Delivery Reviews 48(2001): 3-26.
Lampe et al. J. Med. Chem. 2002, 45, pp. 2624-2643.
Austin, et al.,CAS, 1996, vol. 124, p. 234.
Baker, S., et al., “Discovery of a New Boron-Containing Antifungal Agent, 5-Fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2690) for Potential Treatment of Onychomycosis”,Journal of Medicinal Chemistry, Jul. 27, 2006, vol. 49, No. 15; pp. 4447-4450.
Baker, S. J., et al., “Progress on New Therapeutics for Fungal Nail Infections,”Annual Reports in Medicinal Chemistry, 2005, vol. 40; pp. 323-335.
Bessis, N., “Gene Therapy for Rheumatoid Arthritis,”J. Gene Med, 2002, vol. 4, pp. 581-591.
Ferrer. “Targeting Aminocytl-tRNA Synthetases for the Treatment of Fungal Infections”,Drug News Perspective, Jul.-Aug. 2006, vol. 19, No. 6; pp. 347-348.
Murdan, S., et al., “Drug Delivery to the Nail Following Topical Application,”International Journal of Pharmaceutics, 2002, vol. 236; pp. 1-26.
Zhou, Huchen, et al., “Hemodextrin: a Self-assembled Cyclodextrin-Porphyrin Construct That Binds Dioxygen,”Biophysical Chemistry, 2003, vol. 105; pp. 639-648.
Zhou, Huchen, et al., “Structure-activity Studies on a Library of Potent Calix[4]arene-based PDGF Antagonists that Inhibit PDGF-stimulated PDGFR Tyrosine Phosphorylation,”Org. Biomol. Chem., 2006, vol. 4; pp. 2376-2386.
Zhou, Huchen, et al., “Pattern Recognition of Proteins Based on an Array of Functionalized Porphyrins,”J. Am. Chem. Soc., 2006, vol. 128 pp. 2421-2425.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Boron-containing small molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Boron-containing small molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Boron-containing small molecules will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4175948

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.